Zeronda Tyler Insider Trades

Insider Trading History

Track insider trading activity for Zeronda Tyler. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $65.5k 99,788 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.4k 4,007 shares
$0.60
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $68.1k 103,795 shares
Last Trade
Dec 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.56k 7,858 shares
$0.58
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $73.2k 111,653 shares
Last Trade
Sep 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.16k 3,420 shares
$0.34
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $75.5k 115,073 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.64k 3,420 shares
$1.65
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $77.7k 118,493 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.3k 8,399 shares
$1.58
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $151k 230,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$637k 230,000 shares
$2.77
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $83.2k 126,892 shares
Last Trade
Dec 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.7k 4,675 shares
$3.35
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $86.3k 131,567 shares
Last Trade
Sep 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$158 84 shares
$1.88
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $86.4k 131,651 shares
Last Trade
Jul 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$177 92 shares
$1.92
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF FINANCIAL OFFICER
Holding Value $86.4k 131,743 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$290 94 shares
$3.08
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $86.5k 131,837 shares
Last Trade
Jan 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$212 93 shares
$2.28
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $86.5k 131,930 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146k 62,500 shares
$2.33
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $45.5k 69,430 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 62,500 shares
$2.70
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $4.55k 6,930 shares
Last Trade
Oct 02, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.16k 1,087 shares
$3.83
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $5.26k 8,017 shares
Last Trade
Jun 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$373 91 shares
$4.10
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $5.32k 8,108 shares
Last Trade
Mar 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.18k 384 shares
$3.08
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Financial Officer
Holding Value $113k 173,005 shares
Last Trade
Dec 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$53.1 354 shares
$0.15
$0.66
Menlo Therapeutics
Menlo Therapeutics MNLO
CFO
Holding Value $0 173,359 shares
Last Trade
Sep 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
VYNE Therapeutics
VYNE Therapeutics VYNE
CFO
Holding Value $114k 173,359 shares
Last Trade
Sep 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$77.7 353 shares
$0.22
$0.66
Menlo Therapeutics
Menlo Therapeutics MNLO
CFO
Holding Value $0 173,712 shares
Last Trade
Jun 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up